CD33 and acute myeloid leukemia: Minagawa and colleagues showed that the retroviral transduction of activated T cells (ATCs) with a construct encoding the iCasp9 and an anti-CD33 CAR allows to efficiently redirect T lymphocytes against CD33+ AML cells, including pAML samples.